Separately, researchers observed that patients with malignant or viral disease occasionally developed a lupus-like syndrome after IFNα administration, which suggests a causative relationship between IFN and lupus pathogenesis [35]. The gene discussed is IFNA1; the disease is systemic lupus erythematosus.